Hydrocortisone (Ala-Cort, Ala-Scalp, Anusol HC) — 2026 Medicare Part D coverage
hydrocortisone — sold as Ala-Cort, Ala-Scalp, Anusol HC, Cortef, Khindivi, Procto-Med, Proctosol, Proctozone HC, Texacort: 28 forms appear in Medicare Part D formularies for 2026. This page reports what plans filed with CMS; it does not recommend a plan.
Which plans in your county cover hydrocortisone?
Pick a county to see every Medicare Advantage plan filed there and every stand-alone Part D plan in its region, with this drug's tier, restrictions and tier cost sharing.
How to read drug coverage
Tier is the cost-sharing tier the plan assigned the drug in its CMS formulary filing; lower tiers usually cost less. PA = prior authorization, ST = step therapy (try another drug first), QL = quantity limit. Not on formulary means the plan did not list this exact form; the plan may cover another strength or a formulary exception may be possible. Cost sharing is the plan's initial-coverage amount for the tier as filed with CMS; the deductible, the $2,100 annual out-of-pocket cap, the $35 insulin cap and negotiated prices for selected drugs can change what you actually pay. Formularies change during the year; the plan's formulary document and Medicare.gov govern.
What the star rating under each Medicare Advantage plan means
What the star rating means. CMS rates every Medicare Advantage contract (the "H" number in the plan ID — all plans under it share the rating) on a 1-to-5 scale each October, from about 40 measures of care quality, member experience, complaints and appeals, customer service and, for plans with drug coverage, drug safety and pricing. The 2026 rating is largely based on performance measured in 2024.
5 Excellent4 Above average3 Average2 Below average1 Poor
Not rated means CMS published no overall rating — usually a contract too new to be measured or with too few members ("not enough data"); it is not a low score. A 5-star contract can be joined outside the normal enrollment windows (the 5-star Special Enrollment Period, Dec 8 – Nov 30). Medicare.gov flags contracts rated below 3 stars for three years running as low-performing. Stars describe the contract's past performance as CMS measured it; they are not a recommendation, and they do not tell you whether a plan's network, drugs or costs fit you.
Forms and strengths in 2026 formularies
| Form | Formularies listing it | Most common tier | PA | ST | QL |
|---|---|---|---|---|---|
| hydrocortisone 10 MG Oral Tablet generic · RxCUI 197782 | 328 (100%) | 2 | 0 | 0 | 0 |
| hydrocortisone 2.5 % Topical Cream generic · RxCUI 310891 | 328 (100%) | 2 | 0 | 0 | 91 |
| hydrocortisone 2.5 % Topical Ointment generic · RxCUI 103401 | 328 (100%) | 2 | 0 | 0 | 87 |
| hydrocortisone 20 MG Oral Tablet generic · RxCUI 197783 | 328 (100%) | 2 | 0 | 0 | 0 |
| hydrocortisone 5 MG Oral Tablet generic · RxCUI 197787 | 328 (100%) | 2 | 0 | 0 | 0 |
| hydrocortisone 100 MG in 60 mL Rectal Enema generic · RxCUI 310878 | 326 (99%) | 4 | 0 | 0 | 0 |
| hydrocortisone 1 % Topical Cream generic · RxCUI 106258 | 323 (98%) | 1 | 0 | 0 | 39 |
| hydrocortisone 2.5 % Topical Lotion generic · RxCUI 197785 | 323 (98%) | 2 | 0 | 0 | 96 |
| Procto-Med HC 2.5 % Topical Cream brand · RxCUI 1790684 | 310 (95%) | 2 | 0 | 0 | 89 |
| Proctozone HC 2.5 % Topical Cream brand · RxCUI 1440936 | 309 (94%) | 2 | 0 | 0 | 90 |
| Proctosol-HC 2.5 % Topical Cream brand · RxCUI 1540356 | 306 (93%) | 2 | 0 | 0 | 90 |
| hydrocortisone 1 % Topical Ointment generic · RxCUI 203105 | 277 (84%) | 2 | 0 | 0 | 90 |
| Alacort 1 % Topical Cream brand · RxCUI 206347 | 251 (77%) | 2 | 0 | 0 | 0 |
| hydrocortisone valerate 0.2 % Topical Cream generic · RxCUI 1370754 | 223 (68%) | 2 | 0 | 0 | 103 |
| hydrocortisone butyrate 0.1 % Topical Ointment generic · RxCUI 1370758 | 96 (29%) | 4 | 0 | 0 | 47 |
| hydrocortisone valerate 0.2 % Topical Ointment generic · RxCUI 1370750 | 90 (27%) | 4 | 0 | 0 | 17 |
| hydrocortisone butyrate 0.1 % Topical Cream generic · RxCUI 1370770 | 70 (21%) | 4 | 0 | 0 | 33 |
| hydrocortisone butyrate 0.1 % Topical Solution generic · RxCUI 1370767 | 52 (16%) | 2 | 0 | 0 | 20 |
| hydrocortisone butyrate 0.1 % Topical Lotion generic · RxCUI 1370763 | 20 (6%) | 2 | 0 | 0 | 8 |
| Ala-Scalp HP 2 % Topical Lotion brand · RxCUI 884077 | 10 (3%) | 1 | 0 | 0 | 0 |
| hydrocortisone 2 % Topical Lotion generic · RxCUI 197784 | 9 (3%) | 2 | 0 | 0 | 0 |
| Anusol-HC 2.5 % Topical Cream brand · RxCUI 1659445 | 2 (1%) | 1 | 0 | 0 | 1 |
| Khindivi 1 MG/mL Oral Solution brand · RxCUI 2716556 | 2 (1%) | 5 | 0 | 0 | 0 |
| hydrocortisone 2.5 % Topical Solution generic · RxCUI 197786 | 2 (1%) | 4 | 0 | 0 | 0 |
| Cortef 10 MG Oral Tablet brand · RxCUI 208712 | 1 (0%) | 1 | 0 | 0 | 0 |
| Cortef 20 MG Oral Tablet brand · RxCUI 208816 | 1 (0%) | 1 | 0 | 0 | 0 |
| Cortef 5 MG Oral Tablet brand · RxCUI 208680 | 1 (0%) | 1 | 0 | 0 | 0 |
| Texacort 2.5 % Topical Solution brand · RxCUI 206336 | 1 (0%) | 4 | 0 | 0 | 0 |
Counts are formularies (of 328) in the CMS file that list the form, and how many of those apply prior authorization (PA), step therapy (ST) or a quantity limit (QL). Many plans share one formulary, so plan counts in a county will differ.
How to read drug coverage
Tier is the cost-sharing tier the plan assigned the drug in its CMS formulary filing; lower tiers usually cost less. PA = prior authorization, ST = step therapy (try another drug first), QL = quantity limit. Not on formulary means the plan did not list this exact form; the plan may cover another strength or a formulary exception may be possible. Cost sharing is the plan's initial-coverage amount for the tier as filed with CMS; the deductible, the $2,100 annual out-of-pocket cap, the $35 insulin cap and negotiated prices for selected drugs can change what you actually pay. Formularies change during the year; the plan's formulary document and Medicare.gov govern.
What the star rating under each Medicare Advantage plan means
What the star rating means. CMS rates every Medicare Advantage contract (the "H" number in the plan ID — all plans under it share the rating) on a 1-to-5 scale each October, from about 40 measures of care quality, member experience, complaints and appeals, customer service and, for plans with drug coverage, drug safety and pricing. The 2026 rating is largely based on performance measured in 2024.
5 Excellent4 Above average3 Average2 Below average1 Poor
Not rated means CMS published no overall rating — usually a contract too new to be measured or with too few members ("not enough data"); it is not a low score. A 5-star contract can be joined outside the normal enrollment windows (the 5-star Special Enrollment Period, Dec 8 – Nov 30). Medicare.gov flags contracts rated below 3 stars for three years running as low-performing. Stars describe the contract's past performance as CMS measured it; they are not a recommendation, and they do not tell you whether a plan's network, drugs or costs fit you.